{ "METABOLOMICS WORKBENCH":{"STUDY_ID":"ST001326","ANALYSIS_ID":"AN002208","VERSION":"1","CREATED_ON":"March 10, 2020, 4:58 pm"}, "PROJECT":{"PROJECT_TITLE":"Untargeted lipidome changes in Chlamydomonas reinhardtii treated with small molecules containing adamantane structures","PROJECT_SUMMARY":"A study to investigate the effect of small molecule lipid inducing compounds that leads to hyper accumulation of lipids in N replete cells of Chlamydomonas reinhardtii. These compounds were identified through a high throughput screening designed for that purpose. During that screening, we screened 43,783 compounds and identified 367 primary hits. These 367 hits were further retested using a 8-point dilution series (from 0.25 to 30 uM) and verified the activity of 250 compounds that induce the hyper lipid accumulating phenotype in algae. Once the hit compounds were identified and confirmed, we then performed extensive chemoinformatics analysis to look for common scaffolds and identified several common substructures. We then selected 15 top performing compounds from 5 diverse structural groups and tested biochemical parameters such as growth, lipid accumulating capacity, effect on photosynthetic rates, respiration rates, oxygen consumption rates, analysis of different lipid species to quantify and identify fatty acid species using GC-MS. To understand the global changes in the lipidome, 2 structurally similar compounds were selected and compared with cells grown without compounds as control for untargeted lipidome analysis.","INSTITUTE":"University of Nebraska-Lincoln","DEPARTMENT":"Biochemistry","LABORATORY":"FATTTLab","LAST_NAME":"Wase","FIRST_NAME":"Nishikant","ADDRESS":"1901 Beadle Center, Vine Street, 1901 VINE STREET, Lincoln, NE, 68588-0664, USA","EMAIL":"nishikant.wase@gmail.com","PHONE":"4023109931","FUNDING_SOURCE":"NCESR-704, Nebraska Center for Energy Science Research; EPS-1004094 and 1264409, National Science Foundation ; NSF CBET : 1402896, National Science Foundation","CONTRIBUTORS":"Nishikant Wase, Jiri Adamec, Ron Cerny, Girish Rasineni, Paul N Black, Concetta DiRusso"}, "STUDY":{"STUDY_TITLE":"Untargeted lipidome changes in Chlamydomonas reinhardtii treated with small molecules containing adamantane structures","STUDY_SUMMARY":"A study to investigate the effect of small molecule lipid inducing compounds that leads to hyper accumulation of lipids in N replete cells of Chlamydomonas reinhardtii. These compounds were identified through a high throughput screening designed for that purpose. During that screening, we screened 43,783 compounds and identified 367 primary hits. These 367 hits were further retested using a 8-point dilution series (from 0.25 to 30 uM) and verified the activity of 250 compounds that induce the hyper lipid accumulating phenotype in algae. Once the hit compounds were identified and confirmed, we then performed extensive chemoinformatics analysis to look for common scaffolds and identified several common substructures. We then selected 15 top performing compounds from 5 diverse structural groups and tested biochemical parameters such as growth, lipid accumulating capacity, effect on photosynthetic rates, respiration rates, oxygen consumption rates, analysis of different lipid species to quantify and identify fatty acid species using GC-MS. To understand the global changes in the lipidome, 2 structurally similar compounds were selected and compared with cells grown without compounds as control for untargeted lipidome analysis.","INSTITUTE":"University of Nebraska-Lincoln","DEPARTMENT":"Department of Biochemistry","LAST_NAME":"Wase","FIRST_NAME":"Nishikant","ADDRESS":"Department of Biochemistry, 1901 VINE STREET","EMAIL":"nishikant.wase@gmail.com","PHONE":"4023109931"}, "SUBJECT":{"SUBJECT_TYPE":"Photosynthetic organism","SUBJECT_SPECIES":"Chlamydomonas reinhardtii","TAXONOMY_ID":"3055","GENOTYPE_STRAIN":"CC125 Wild type"}, "SUBJECT_SAMPLE_FACTORS":[ { "Subject ID":"-", "Sample ID":"Nplus_A", "Factors":{"Group":"Cont"}, "Additional sample data":{"RAW_FILE_NAME":"NplusA.mzXML"} }, { "Subject ID":"-", "Sample ID":"Nplus_C", "Factors":{"Group":"Cont"}, "Additional sample data":{"RAW_FILE_NAME":"NplusC.mzXML"} }, { "Subject ID":"-", "Sample ID":"Nplus_B", "Factors":{"Group":"Cont"}, "Additional sample data":{"RAW_FILE_NAME":"NplusB.mzXML"} }, { "Subject ID":"-", "Sample ID":"542_a", "Factors":{"Group":"WD20542"}, "Additional sample data":{"RAW_FILE_NAME":"542a.mzXML"} }, { "Subject ID":"-", "Sample ID":"542_b", "Factors":{"Group":"WD20542"}, "Additional sample data":{"RAW_FILE_NAME":"542b.mzXML"} }, { "Subject ID":"-", "Sample ID":"542_c", "Factors":{"Group":"WD20542"}, "Additional sample data":{"RAW_FILE_NAME":"542c.mzXML"} }, { "Subject ID":"-", "Sample ID":"067_b", "Factors":{"Group":"WD20067"}, "Additional sample data":{"RAW_FILE_NAME":"067b.mzXML"} }, { "Subject ID":"-", "Sample ID":"067_c", "Factors":{"Group":"WD20067"}, "Additional sample data":{"RAW_FILE_NAME":"067c.mzXML"} }, { "Subject ID":"-", "Sample ID":"067_a", "Factors":{"Group":"WD20067"}, "Additional sample data":{"RAW_FILE_NAME":"067a.mzXML"} } ], "COLLECTION":{"COLLECTION_SUMMARY":"For lipid analysis, cells were grown in TAP media and treated with compounds at a final concentration of 5 µM. After 72h of growth, cells were harvested, media removed the biomass was lyophilized overnight at -50 °C. For lipid extraction dry biomass powder was accurately weighed 10 ± 0.5 milligram and resuspended in chloroform:methanol (2:1; 0.01% butylated hydroxytoluene (BHT)). The cell lysis was performed using bead mill (Qiagen TissueLyser LT, Qiagen Valencia, CA) for 5 min at 50 Hz power and further incubated for 30 min in a multi-tube vortexer (Fischer Scientific). Lower lipid phase was retrieved and transferred to a new clean tube and samples re-extracted. Both lipid phases were pooled together lipids were shaken first with 0.8% aqueous potassium chloride solution and then water. The organic phase was transferred to fresh tube and evaporated under the stream of nitrogen. The dried lipid samples were flushed with nitrogen and stored at -80 °C until analyzed on FT-MS.","SAMPLE_TYPE":"Algae","COLLECTION_METHOD":"Centrifugation from suspension culture.","COLLECTION_LOCATION":"FATTTLab Department of Biochemistry, Univ of Nebraska-Lincoln","STORAGE_CONDITIONS":"After harvest, cells were kept at -80 C until extraction.","COLLECTION_VIALS":"2 mL Eppendorf tubes"}, "TREATMENT":{"TREATMENT_SUMMARY":"For compound treatment, cells from mid-log phase culture were harvested, washed once with fresh sterile TAP media and inoculated at starting density of 5 x 105 cells/mL. Thus for the current experiment 3 different treatment conditions were generated. Cells without compound treatment were negative control for the lipid accumulation and 2 compounds were used to generate treatment conditions. All compounds were used at a final concentration of 5 uM (this concentration was determined using a dose-response curve). For all cultures, 250 mL Erlenmeyer flasks with rubber stopper adopted to facilitate gas exchange were used and maintained in horizontal orbital shaking growing chamber (Innova 43; New Brunswick). At the end of 72h, cells were harvested, media was removed via centrifugation and biomass was stored at -80 C until lipids extraction."}, "SAMPLEPREP":{"SAMPLEPREP_SUMMARY":"For lipid analysis, cells were grown in TAP media and treated with compounds at a final concentration of 5 µM. After 72h of growth, cells were harvested, media removed the biomass was lyophilized overnight at -50 °C. For lipid extraction dry biomass powder was accurately weighed 10 ± 0.5 milligram and resuspended in chloroform:methanol (2:1; 0.01% butylated hydroxytoluene (BHT)). The cell lysis was performed using bead mill (Qiagen TissueLyser LT, Qiagen Valencia, CA) for 5 min at 50 Hz power and further incubated for 30 min in a multi-tube vortexer (Fischer Scientific). Lower lipid phase was retrieved and transferred to a new clean tube and samples re-extracted. Both lipid phases were pooled together lipids were shaken first with 0.8% aqueous potassium chloride solution and then water. The organic phase was transferred to fresh tube and evaporated under the stream of nitrogen. The dried lipid samples were flushed with nitrogen and stored at -80 °C until analyzed on FT-MS.","EXTRACTION_METHOD":"Bead beating"}, "CHROMATOGRAPHY":{"CHROMATOGRAPHY_SUMMARY":"The dried lipid samples were retrieved from -80 °C and dissolved into methanol:chloroform (1:1). FTICR-MS analysis was performed using an Agilent 1200 Series HPCL coupled to a 7.05 T Solarix FT-ICR (Bruker) equipped with an ESI source and controlled by HyStar v3.4.8.0 software. Five microliter of samples were injected onto an Ace 5 C8-300 column (2.1 x 100 mm) at a flow rate of 0.1 ml/min. Initial HPLC conditions consisted of 70% Solvent A (0.1% FA; 10 mM ammonium acetate in water) and 30% Solvent B (0.1% FA; 10 mM ammonium acetate in acetonitrile). Samples were eluted using the following gradient: 30% B held for 1 minute, increased to 100% B over 24 minutes and held for 20 minutes. The column was returned to initial conditions of 30% B over 2 minutes then allowed to re-equilibrate over 13 minutes.","CHROMATOGRAPHY_TYPE":"Reversed phase","INSTRUMENT_NAME":"Agilent 1200 Series HPLC","COLUMN_NAME":"ACE 5 C8-300 (100 x 2.1mm)","FLOW_RATE":"0.1 mL/min","SOLVENT_A":"0.1% FA; 10 mM ammonium acetate in water","SOLVENT_B":"0.1% FA; 10 mM ammonium acetate in acetonitrile","SAMPLE_INJECTION":"5 uL"}, "ANALYSIS":{"ANALYSIS_TYPE":"MS","DETECTOR_TYPE":"FT-ICR MS"}, "MS":{"INSTRUMENT_NAME":"Bruker Solarix FT-ICR-MS","INSTRUMENT_TYPE":"FT-ICR","MS_TYPE":"ESI","ION_MODE":"POSITIVE","MS_COMMENTS":"Accurate MS analysis was performed on Bruker 7.05 T Solarix FT-ICR. Mass spectra were acquired in the positive ionization mode from m/z 150.58 to 2500 at a resolving power of 49,000. Capillary voltage was 4500 V with the end plate offset voltage set to -500 V. Drying temperature was set to 180 °C and with a drying gas flow rate of 4 L/min and nebulizer gas flow set to 1.0 bar. Immediately prior to acquisition the instrument was calibrated in the positive ESI mode using NaTFA clusters. Raw MS spectra were converted to mzXML format using CompassXport v. 3.0.6 and processed by Mzmine v 2.2.4. Feature detection was done on the centrioded data using a noise level of 1.0E06 intensity. Once the masses were detected then FTMS shoulder peak filtering was performed using Lorentzian extended algorithm and chromatograms were build using a min time span of 0.1 min, minimum height of 1.0E06 intensity and m/z tolerance was set at 10 ppm. Peak smoothing was performed using Savitzky-Golay algorithm with a filter width of 3. Chromatograms were deconvulated using Savitzky-Golay algorithm using minimum peak height set at 1.0E06 intensity. Finally all the peak lists were aligned using Join aligner method using mz tolerance of 10 ppm, RT tolerance of 0.5 min. The aligned peak list rows were filtered using duplicated peak list filter to obtain 3448 peaks. The missing peak data was recovered using the Gap filling method using the intensity tolerance of 0.1, mz tolerance of 10 ppm and RT tolerance of 0.5 min. RT correction was allowed at this stage. These peaks were identified using Lipid Search module within the mzMine 2. Potential lipids were annotated according to there accurate mass on MS1 level with following setting. Minimum number of carbon set to 28 and max to 60, max number of double bonds set to 10, m/z tolerance was set to 0.001 Da. Then search was performed with two ionization mode [M+H]+ and [M+NH4]+ to obtain identification on 353 peaks. Peak areas along with identification, m/z, retention time were exported out and brought into R environment for univariate and multivariate analysis.","MS_RESULTS_FILE":"ST001326_AN002208_Results.txt UNITS:intesity Has m/z:Yes Has RT:Yes RT units:Minutes"} }